As of 2026-10-17, the Relative Valuation of Immunitybio Inc (IBRX) is (25.58) USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.18 USD, the upside of Immunitybio Inc based on Relative Valuation is -378.7%.
The range of the Relative Valuation is (25.49) - (25.62) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 26.9x - 28.2x | 27.2x |
| Forward P/E multiples | 25.4x - 27.0x | 26.8x |
| Fair Price | (25.49) - (25.62) | (25.58) |
| Upside | -377.6% - -379.1% | -378.7% |
| Date | P/E |
| 2026-10-15 | -10.55 |
| 2026-10-14 | -10.46 |
| 2026-10-13 | -10.34 |
| 2026-10-12 | -10.68 |
| 2026-10-09 | -11.09 |
| 2026-10-08 | -10.46 |
| 2026-10-07 | -10.29 |
| 2026-10-06 | -10.23 |
| 2026-10-05 | -10.96 |
| 2026-10-02 | -10.85 |
| 2026-10-01 | -9.79 |
| 2026-09-30 | -9.96 |
| 2026-09-29 | -9.32 |
| 2026-09-28 | -8.99 |
| 2026-09-25 | -8.91 |
| 2026-09-24 | -9.12 |
| 2026-09-23 | -9.11 |
| 2026-09-22 | -9.80 |
| 2026-09-21 | -8.92 |
| 2026-09-18 | -8.95 |
| 2026-09-17 | -8.93 |
| 2026-09-16 | -8.35 |
| 2026-09-15 | -8.59 |
| 2026-09-14 | -8.83 |
| 2026-09-11 | -8.35 |
| 2026-09-10 | -8.15 |
| 2026-09-09 | -8.51 |
| 2026-09-08 | -8.75 |
| 2026-09-04 | -8.53 |
| 2026-09-03 | -8.64 |
| 2026-09-02 | -8.39 |
| 2026-09-01 | -8.31 |
| 2026-08-31 | -8.39 |
| 2026-08-28 | -8.50 |
| 2026-08-27 | -8.87 |
| 2026-08-26 | -8.71 |
| 2026-08-25 | -8.64 |
| 2026-08-24 | -8.00 |
| 2026-08-21 | -8.22 |
| 2026-08-20 | -8.27 |
| 2026-08-19 | -8.58 |
| 2026-08-18 | -8.15 |
| 2026-08-17 | -8.36 |
| 2026-08-14 | -7.99 |
| 2026-08-13 | -8.07 |
| 2026-08-12 | -8.17 |
| 2026-08-11 | -8.02 |
| 2026-08-10 | -7.91 |
| 2026-08-07 | -8.06 |
| 2026-08-06 | -7.73 |